...
首页> 外文期刊>Scandinavian journal of pain >Colored body images reveal the perceived intensity and distribution of pain in women with breast cancer treated with adjuvant taxanes: a prospective multi-method study of pain experiences
【24h】

Colored body images reveal the perceived intensity and distribution of pain in women with breast cancer treated with adjuvant taxanes: a prospective multi-method study of pain experiences

机译:彩色的身体图像揭示了用佐剂紫杉烷治疗的乳腺癌患者患有患者疼痛的感知强度和分布:疼痛经验的前瞻性多方法研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background and aims: Breast cancer is the most prevalent adult cancer worldwide. A broader use of screening for early detection and adjuvant systemic therapy with chemotherapy has resulted in improved survival rates. Taxane-containing chemotherapy is one of the cornerstones of the treatment. However, taxane-containing chemotherapy may result in acute chemotherapy-induced nociceptive and neuropathic pain. Since this pain may be an additional burden for the patient both during and after taxane chemotherapy, it is important to rapidly discover and treat it. There is yet no gold standard for assessing taxane-induced pain. In the clinic, applying multiple methods for collecting information on pain may better describe the patients' pain experiences. The aim was to document the pain during and after taxane through the contribution of different methods for collecting information on taxane-induced pain. Fifty-three women scheduled for adjuvant sequential chemotherapy at doses of >75 mg/m2 of doc-etaxel and epirubicin were enrolled in the study.
机译:背景和目标:乳腺癌是全世界最普遍的成人癌症。更广泛地使用筛选早期检测和佐剂全身治疗的化疗导致了提高的存活率。含紫杉烷化疗是治疗的基石之一。然而,含紫杉烷的化疗可能导致急性化疗诱导的伤害性和神经性疼痛。由于这种痛苦可能是紫杉烷化疗期间和之后患者的额外负担,因此快速发现和治疗它是重要的。目前还没有用于评估紫杉烷诱导的疼痛的黄金标准。在诊所中,应用多种方法用于收集有关疼痛的信息,可能更好地描述患者的痛苦经历。目的是通过对紫杉烷诱导的疼痛信息的不同方法的贡献来记录紫杉烷期间和之后的痛苦。预定为辅助序贯化学疗法的五十三名女性> 75mg / m 2的Doc-eTaxel和Epirubicin的辅助化学疗法进行了纳入该研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号